Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian G Hartinger

Showing results (171-180 of 190) with videos related to

Pageof 19
Sort By:
Chemmedchem|July 1, 2021
Triazolyl-Functionalized N-Heterocyclic Carbene Half-Sandwich Compounds: Coordination Mode, Reactivity and in vitro Anticancer ActivityKelvin K H Tong, Muhammad Hanif, Sanam Movassaghi, et al.
Journal of Medicinal Chemistry|October 5, 2010
{(1R,2R,4R)-4-methyl-1,2-cyclohexanediamine}oxalatoplatinum(II): a novel enantiomerically pure oxaliplatin derivative showing improved anticancer activity in vivoSergey A Abramkin, Ute Jungwirth, Seied M Valiahdi, et al.
Metallomics : Integrated Biometal Science|October 9, 2019
Chemical imaging and assessment of cadmium distribution in the human bodyAlexander E Egger, Gerlinde Grabmann, Can Gollmann-Tepeköylü, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 14, 2015
Half-sandwich ruthenium(II) biotin conjugates as biological vectors to cancer cellsMaria V Babak, Damian Plażuk, Samuel M Meier, et al.
European Journal of Medicinal Chemistry|October 9, 2018
Hybrid compounds from chalcone and 1,2-benzothiazine pharmacophores as selective inhibitors of alkaline phosphatase isozymesAdnan Ashraf, Syeda Abida Ejaz, Shafiq Ur Rahman, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 10, 2024
Masking the Bioactivity of Hydroxamic Acids by Coordination to Cobalt: Towards Bioreductive Anticancer AgentsDavid M Goodman, Cornelia U Ritter, Erin Chen, et al.
Molecular Pharmacology|February 15, 2012
Anticancer activity of methyl-substituted oxaliplatin analogsUte Jungwirth, Dimitris N Xanthos, Johannes Gojo, et al.
Angewandte Chemie (International Ed. in English)|May 21, 2020
A Multitargeted Approach: Organorhodium Anticancer Agent Based on Vorinostat as a Potent Histone Deacetylase InhibitorMuhammad Hanif, Jahanzaib Arshad, Jonathan W Astin, et al.
Journal of Medicinal Chemistry|November 9, 2012
Structure-activity relationships of targeted RuII(η6-p-cymene) anticancer complexes with flavonol-derived ligandsAndrea Kurzwernhart, Wolfgang Kandioller, Simone Bächler, et al.
Inorganic Chemistry|February 15, 2018
Rollover Cyclometalated Bipyridine Platinum Complexes as Potent Anticancer Agents: Impact of the Ancillary Ligands on the Mode of ActionMaria V Babak, Martin Pfaffeneder-Kmen, Samuel M Meier-Menches, et al.
Pageof 19

Showing results (171-180 of 190) with videos related to

Sort By:
Pageof 19
Chemmedchem|July 1, 2021
Triazolyl-Functionalized N-Heterocyclic Carbene Half-Sandwich Compounds: Coordination Mode, Reactivity and in vitro Anticancer ActivityKelvin K H Tong, Muhammad Hanif, Sanam Movassaghi, et al.
Journal of Medicinal Chemistry|October 5, 2010
{(1R,2R,4R)-4-methyl-1,2-cyclohexanediamine}oxalatoplatinum(II): a novel enantiomerically pure oxaliplatin derivative showing improved anticancer activity in vivoSergey A Abramkin, Ute Jungwirth, Seied M Valiahdi, et al.
Metallomics : Integrated Biometal Science|October 9, 2019
Chemical imaging and assessment of cadmium distribution in the human bodyAlexander E Egger, Gerlinde Grabmann, Can Gollmann-Tepeköylü, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 14, 2015
Half-sandwich ruthenium(II) biotin conjugates as biological vectors to cancer cellsMaria V Babak, Damian Plażuk, Samuel M Meier, et al.
European Journal of Medicinal Chemistry|October 9, 2018
Hybrid compounds from chalcone and 1,2-benzothiazine pharmacophores as selective inhibitors of alkaline phosphatase isozymesAdnan Ashraf, Syeda Abida Ejaz, Shafiq Ur Rahman, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 10, 2024
Masking the Bioactivity of Hydroxamic Acids by Coordination to Cobalt: Towards Bioreductive Anticancer AgentsDavid M Goodman, Cornelia U Ritter, Erin Chen, et al.
Molecular Pharmacology|February 15, 2012
Anticancer activity of methyl-substituted oxaliplatin analogsUte Jungwirth, Dimitris N Xanthos, Johannes Gojo, et al.
Angewandte Chemie (International Ed. in English)|May 21, 2020
A Multitargeted Approach: Organorhodium Anticancer Agent Based on Vorinostat as a Potent Histone Deacetylase InhibitorMuhammad Hanif, Jahanzaib Arshad, Jonathan W Astin, et al.
Journal of Medicinal Chemistry|November 9, 2012
Structure-activity relationships of targeted RuII(η6-p-cymene) anticancer complexes with flavonol-derived ligandsAndrea Kurzwernhart, Wolfgang Kandioller, Simone Bächler, et al.
Inorganic Chemistry|February 15, 2018
Rollover Cyclometalated Bipyridine Platinum Complexes as Potent Anticancer Agents: Impact of the Ancillary Ligands on the Mode of ActionMaria V Babak, Martin Pfaffeneder-Kmen, Samuel M Meier-Menches, et al.
Pageof 19